Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up to 10% revenue ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...
With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...
As a damning report finds all four UK governments failed to appreciate the scale of the threat posed by COVID-19 or the ...
TipRanks on MSN
CDC webpage says vaccines may cause autism, WSJ reports
A CDC webpage now states that studies have not ruled out the possibility that infant vaccines cause autism, revising its previous stance, The Wall ...
Newser on MSN
Pfizer's New Flu Shot Could Be a 'Game Changer'
A new mRNA-based flu vaccine from Pfizer has shown greater effectiveness than the standard flu shot in a large Phase 3 trial, according to results published in the New England Journal of Medicine. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback